posted on 2010-05-07, 00:00authored byJohannes A. Burkhard, Carine Guérot, Henner Knust, Mark Rogers-Evans, Erick M. Carreira
Straightforward access toward previously unreported substituted, heterocyclic spiro[3.3]heptanes is disclosed. These spirocyclic systems may be considered as alternatives to 1,3-heteroatom-substituted cyclohexanes, which are otherwise insufficiently stable to allow their use in drug discovery. Conformational details are discussed on the basis of X-ray crystallographic structures.